Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
for
Pain, Sickle Cell Disease
Location: Hartford CT, New York NY, Newark NJ, Rochester NY,
Sponsor: University of Pittsburgh
Sex: All
Age: 16 - 39
Code: NCT06374238
Recruiting
Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
for
Caregiver Anxiety, Caregiver Anxiety Related to Cancer Imaging,
Location: Hartford CT
Sponsor: Kimberley Roche
Sex: All
Age: 18+
Code: NCT07420101
Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Hartford CT, Lake Success NY, New York NY, Toronto,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 2 - 17
Code: NCT07158242
Phase 3, Recruiting
Interoceptive Awareness and Function in Adolescents With Chronic Pain
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Hartford CT, The Bronx NY, Worcester MA, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Hartford CT, Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia